Cargando…

Current Progress in Cancer Treatment Using Nanomaterials

The pathological processes of cancer are complex. Current methods used for chemotherapy have various limitations, such as cytotoxicity, multi-drug resistance, stem-like cells growth, and lack of specificity. Several types of nanomaterials are used for cancer treatment. Nanomaterials 1–100 nm in size...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Ruirui, Zhang, Fangyuan, Peng, Yudong, Xie, Tian, Wang, Yi, Lan, Yin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330335/ https://www.ncbi.nlm.nih.gov/pubmed/35912195 http://dx.doi.org/10.3389/fonc.2022.930125

Ejemplares similares

Research Progress of Photothermal Nanomaterials in Multimodal Tumor Therapy
por: Shi, Xiaolu, et al.
Publicado: (2022)

The Application of Nanotechnology and Nanomaterials in Cancer Diagnosis and Treatment: A Review
por: Kher, Chinmay, et al.
Publicado: (2022)

Editorial: Autophagy modulation in cancer treatment utilizing nanomaterials and nanocarriers
por: Cordani, Marco, et al.
Publicado: (2023)

Increased AOC1 Expression Promotes Cancer Progression in Colorectal Cancer
por: Liu, Fangyuan, et al.
Publicado: (2021)

Current status of and progress in the treatment of malignant pleural effusion of lung cancer
por: Zhao, Yuhua, et al.
Publicado: (2023)

PPAR-γ Modulators as Current and Potential Cancer Treatments
por: Chi, Tiange, et al.
Publicado: (2021)

Nanomaterials for cancer therapy: current progress and perspectives
por: Cheng, Zhe, et al.
Publicado: (2021)

Nanomaterial Technology and Soft Tissue Sarcomas
por: Zhou, Changkai, et al.
Publicado: (2022)

Immune checkpoint inhibitors in cervical cancer: Current status and research progress
por: Xie, Yunkai, et al.
Publicado: (2022)

Nanomaterial Technology and Triple Negative Breast Cancer
por: Hou, Kai, et al.
Publicado: (2022)

Surgical Staging of Locally Advanced Cervical Cancer: Current Status and Research Progress
por: Zhang, He, et al.
Publicado: (2022)

pH-Responsive Polymer Nanomaterials for Tumor Therapy
por: Chu, Shunli, et al.
Publicado: (2022)

Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
por: Gharoonpour, Azar, et al.
Publicado: (2023)

Editorial: Nanomaterials and multimodal tumor therapy
por: Yang, Yongqi, et al.
Publicado: (2022)

Recent advances in the diagnostic and therapeutic roles of microRNAs in colorectal cancer progression and metastasis
por: Liang, Chen, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
por: Liu, Hao-Tian, et al.
Publicado: (2021)

PPAR-α Modulators as Current and Potential Cancer Treatments
por: Tan, Yan, et al.
Publicado: (2021)

Nanomaterial Complexes Enriched With Natural Compounds Used in Cancer Therapies: A Perspective for Clinical Application
por: Saavedra-Leos, María Zenaida, et al.
Publicado: (2021)

Pancreatic cancer and exosomes: role in progression, diagnosis, monitoring, and treatment
por: Fang, Xingliang, et al.
Publicado: (2023)

Recent Advances of Manganese-Based Hybrid Nanomaterials for Cancer Precision Medicine
por: Liu, Xiaoman, et al.
Publicado: (2021)

Current Management and Progress in Radiotherapy for Small Cell Lung Cancer
por: Tjong, Michael C., et al.
Publicado: (2020)

Research progress on deep learning in magnetic resonance imaging–based diagnosis and treatment of prostate cancer: a review on the current status and perspectives
por: He, Mingze, et al.
Publicado: (2023)

Carbonaceous Nanomaterials for Phototherapy of Cancer
por: Gupta, Tanisha, et al.
Publicado: (2023)

Hypoxia-responsive nanomaterials for tumor imaging and therapy
por: Xia, Yifei, et al.
Publicado: (2022)

Two-dimensional nanomaterials beyond graphene for antibacterial applications: current progress and future perspectives
por: Mei, Linqiang, et al.
Publicado: (2020)

Current Evidence Linking Polyunsaturated Fatty Acids with Cancer Risk and Progression
por: Azrad, Maria, et al.
Publicado: (2013)

Exosomes as drug delivery system in gastrointestinal cancer
por: Xie, Fangyuan, et al.
Publicado: (2023)

Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment
por: Acter, Shahinur, et al.
Publicado: (2023)

Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
por: Wu, Shilun, et al.
Publicado: (2022)

Editorial: Diagnosis and treatment of gynecologic malignancies during pregnancy
por: Wang, Yudong, et al.
Publicado: (2023)

Current treatments for non-small cell lung cancer
por: Guo, Qianqian, et al.
Publicado: (2022)

The role of matrix stiffness in breast cancer progression: a review
por: Xu, Ruoxi, et al.
Publicado: (2023)

Impact of intestinal dysbiosis on breast cancer metastasis and progression
por: Zhang, Jin, et al.
Publicado: (2022)

Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma
por: Wang, Yichen, et al.
Publicado: (2022)

GATA6 Exerts Potent Lung Cancer Suppressive Function by Inducing Cell Senescence
por: Chen, Wensheng, et al.
Publicado: (2020)

Camrelizumab Combined With Gemcitabine and Albumin-Bound Paclitaxel for Neoadjuvant Therapy in the Treatment of Progressive Gallbladder Cancer: A Case Report
por: Wu, Jing, et al.
Publicado: (2022)

Current perspectives on clinical use of exosomes as novel biomarkers for cancer diagnosis
por: Yi, Xiaomei, et al.
Publicado: (2022)

Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects
por: Guo, Bin, et al.
Publicado: (2023)

A 20-Year Research Trend Analysis of the Influence of Anesthesia on Tumor Prognosis Using Bibliometric Methods
por: Luo, Jiamei, et al.
Publicado: (2021)

Current Landscape: The Mechanism and Therapeutic Impact of Obesity for Breast Cancer
por: Zhao, Chongru, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3bg414fmm07bn56sfj4rl1r8sl